Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Sep 1.

Published in final edited form as: J Allergy Clin Immunol Pract. 2022 Jan 12:S2213-2198(22)00003-4. doi: 10.1016/j.jaip.2021.12.031

A, The percent of subjects with various indications for initial tryptase measurements. “Other” category includes neuropathy (1 subject), Ehlers Danlos syndrome (2 subjects), gastrointestinal symptoms (4 subjects), and macrocytic anemia (1 subject). B, Specialty of clinicians ordering initial tryptase tests.

A, The percent of subjects with various indications for initial tryptase measurements. “Other” category includes neuropathy (1 subject), Ehlers Danlos syndrome (2 subjects), gastrointestinal symptoms (4 subjects), and macrocytic anemia (1 subject). B, Specialty of clinicians ordering initial tryptase tests.